News

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Kansas City is poised to become a national leader in addressing the nation’s maternal health crisis, and there’s a way for you to help or to be treated if you’re pregnant and have a heart condition.

“U.S. News & World Report” has named Saint Luke’s Hospital of Kansas City, Saint Luke’s East Hospital, and Saint Luke’s North Hospital–Barry Road as 2025 High Performing hospitals for Maternity Care.

Three Saint Luke’s hospitals earn highest award for U.S. News’ Best Hospitals for Maternity Care.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

At 35 weeks pregnant, Sara went into labor—just three days before she and her fiance were supposed to get married. A goal they had before the baby arrived, but their son had other plans.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

In the past, many women born with a heart condition were told they would not be able to birth children safely.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.